Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Physiologic Signal Fusion for 72-Hour Prediction of Acute Clinical Deterioration

NCT07817550 is registered in ClinicalTrials.gov with Truway Health, Inc. as lead sponsor.

NCT NCT07817550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07817550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Physiologic Signal Fusion for 72-Hour Prediction of Acute Clinical Deterioration
Lead sponsor
Truway Health, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 1, 2026
Completion date
March 31, 2039
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute disease, aging, biomarkers, critical illness, digital health, disease progression, remote patient monitoring, wearable electronic devices